ResearcherSir Run Run Shaw HospitalActive in the last 2 years
Chaojie Huang
Matched on OpenAlex author ID A5080821003. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2020: 2 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers
Papers 5
- Targeted delivery of the PKMYT1 inhibitor RP-6306 mediates PANoptosis in pancreatic cancer via mitotic catastrophe. Co-author DOI 10.1038/s41419-025-07835-2↗
- Discovery of CMNPD31124 as a novel marine-derived PKMYT1 inhibitor for pancreatic ductal adenocarcinoma therapy: computational and biological insights. Co-author DOI 10.3389/fphar.2025.1569765↗
- ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.01.013↗
- Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center propensity score matching study. Co-author DOI 10.1007/s13304-020-00742-5↗
- Total laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis with meta-analysis Co-author DOI 10.21203/rs.3.rs-20225/v1↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chaolei Zhang · 2 shared papers, 2022–2025 · strength 0.42
- Paper Targeted delivery of the PKMYT1 inhibitor RP-6306 mediates PANoptosis in pancreatic cancer via mitotic catastrophe. DOI 10.1038/s41419-025-07835-2↗
- Paper ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response … DOI 10.1016/j.canlet.2022.01.013↗
- Liping Cao · 2 shared papers, 2022–2025 · strength 0.42
- Paper Targeted delivery of the PKMYT1 inhibitor RP-6306 mediates PANoptosis in pancreatic cancer via mitotic catastrophe. DOI 10.1038/s41419-025-07835-2↗
- Paper ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response … DOI 10.1016/j.canlet.2022.01.013↗
- Ting Wang · 1 shared paper, 2025 · strength 0.37
- Yunyun Xu · 1 shared paper, 2025 · strength 0.37
- Jingyun Chen · 1 shared paper, 2025 · strength 0.27
- Ke Chen · 2 shared papers, 2020 · strength 0.21
- Paper Total laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matchin… DOI 10.21203/rs.3.rs-20225/v1↗
- Paper Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center propensity score m… DOI 10.1007/s13304-020-00742-5↗
- Qilong Chen · 2 shared papers, 2020 · strength 0.21
- Paper Total laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matchin… DOI 10.21203/rs.3.rs-20225/v1↗
- Paper Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center propensity score m… DOI 10.1007/s13304-020-00742-5↗
- Xian-fa Wang · 2 shared papers, 2020 · strength 0.21
- Paper Total laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matchin… DOI 10.21203/rs.3.rs-20225/v1↗
- Paper Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center propensity score m… DOI 10.1007/s13304-020-00742-5↗
- Liangjing Zhou · 1 shared paper, 2022 · strength 0.15
- Tianshu Pang · 1 shared paper, 2022 · strength 0.15
- Guoping Ding · 1 shared paper, 2022 · strength 0.15
- Shengnan Jia · 1 shared paper, 2022 · strength 0.15
- Miaozun Zhang · 1 shared paper, 2020 · strength 0.11
- Yiping Mou · 1 shared paper, 2020 · strength 0.11
- Yong Wang · 1 shared paper, 2020 · strength 0.11
- Xueyong Zheng · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.